The effect of insulin-like growth factor-I (IGF-I), and an IGF-I-like factor secreted by human lung fibroblasts, on the growth of human lung carcinoma cells in vitro
dc.contributor.author | Ankrapp, David P. | en |
dc.contributor.committeechair | Bevan, David R. | en |
dc.contributor.committeemember | Ebel, Richard E. | en |
dc.contributor.committeemember | Sitz, Thomas O. | en |
dc.contributor.committeemember | Potts, Malcolm | en |
dc.contributor.committeemember | Veit, Hugo P. | en |
dc.contributor.department | Biochemistry and Nutrition | en |
dc.date.accessioned | 2014-03-14T21:20:45Z | en |
dc.date.adate | 2005-10-10 | en |
dc.date.available | 2014-03-14T21:20:45Z | en |
dc.date.issued | 1993-05-05 | en |
dc.date.rdate | 2005-10-10 | en |
dc.date.sdate | 2005-10-10 | en |
dc.description.abstract | The concentration of insulin-like growth factor I (IGF-I) in tissue taken from human non-small cell lung carcinoma (NSCLC) is 1.4- to 7-fold higher than the concentration of IGF-I in the surrounding normal lung tissue and therefore IGF-I may be involved in the growth of NSCLC. In this study it was determined that NSCLC cell lines (A549, A427, SK-LU-1) expressed the type I IGF-I receptor protein and IGF-I stimulated the proliferation of low density plated (2000 cells/cm² growth area) carcinoma cells by 1.6- to 3- fold above control after a four day inCUbation period under serum-free conditions (A549, A427) or in the presence of 0.25% serum (SK-LU-1). In addition, when added to detergent-solubilized type I IGF receptors from A549 cells, IGF-I stimulated [1] a dose-dependent increase in the autophosphorylation of the type I IGF receptor, and [2] a dose-dependent increase (1.5- to 4-fold) in the phosphorylation of a tyrosine kinase-specific substrate. These results suggest that the growth promoting activity of IGF-I for the lung carcinoma cells was mediated through the activation of the type I IGF receptor. | en |
dc.description.degree | Ph. D. | en |
dc.format.extent | xiii, 134 leaves | en |
dc.format.medium | BTD | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.other | etd-10102005-131608 | en |
dc.identifier.sourceurl | http://scholar.lib.vt.edu/theses/available/etd-10102005-131608/ | en |
dc.identifier.uri | http://hdl.handle.net/10919/39726 | en |
dc.language.iso | en | en |
dc.publisher | Virginia Tech | en |
dc.relation.haspart | LD5655.V856_1993.A557.pdf | en |
dc.relation.isformatof | OCLC# 28732754 | en |
dc.rights | In Copyright | en |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | en |
dc.subject.lcc | LD5655.V856 1993.A557 | en |
dc.subject.lcsh | Cancer cells -- Growth | en |
dc.subject.lcsh | Lungs -- Cancer | en |
dc.subject.lcsh | Somatomedin | en |
dc.title | The effect of insulin-like growth factor-I (IGF-I), and an IGF-I-like factor secreted by human lung fibroblasts, on the growth of human lung carcinoma cells in vitro | en |
dc.type | Dissertation | en |
dc.type.dcmitype | Text | en |
thesis.degree.discipline | Biochemistry and Nutrition | en |
thesis.degree.grantor | Virginia Polytechnic Institute and State University | en |
thesis.degree.level | doctoral | en |
thesis.degree.name | Ph. D. | en |
Files
Original bundle
1 - 1 of 1